Human Immunodeficiency Virus (HIV) Infection (cont.)
Triant VA, et al. (2007). Increased acute myocardial infarction rates and cardiovascular risk factors among patients with HIV disease. Journal of Clinical Endocrinology and Metabolism. Available online: http://jcem.endojournals.org/cgi/rapidpdf/jc.2006-2190v1 (e-pub ahead of print).
Chaturvedi AK, et al. (2007). Elevated risk of lung cancer among people with AIDS. AIDS, 21(2): 207–213.
Centers for Disease Control and Prevention (2009). Cases of HIV infection and AIDS in the United States and dependent areas, 2007. HIV/AIDS Surveillance Report, No. 19. Available online: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2007report/default.htm.
Violari A, et al. (2008). Early antiretroviral therapy and mortality among HIV-infected infants. New England Journal of Medicine, 359(21): 2233–2244.
U.S. Department of Health and Human Services (2009). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available online: http://www.aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf.
Centers for Disease Control and Prevention (2005). Updated U.S. Public Health Services guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR, 50(RR-09): 1–17. Available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5409a1.htm.
Centers for Disease Control and Prevention (2005). Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States. Recommendations from the U.S. Department of Health and Human Services. Available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm.
Braithwaite RS, et al. (2008). Influence of alternative thresholds for initiating HIV treatment on quality-adjusted life expectancy: A decision model. Annals of Internal Medicine, 148(3): 178–185.
Hammer, Scott M, et al. (2008). Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society USA Panel. JAMA, 300 (5): 555–570.
U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents (2011). Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Available online: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
U.S. Centers for Disease Control and Prevention (2011). Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR, 60(03): 65–68. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6003a1.htm.
U.S. Centers for Disease Control and Prevention (2011). CDC trial and another major study find PrEP can reduce risk of HIV infection among heterosexuals. Available online: http://www.cdc.gov/nchhstp/newsroom/PrEPHeterosexuals.html.
Cohen MS, et al. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, July 18, epub ahead of print (doi:10.1056/NEJMoa1105243).
Other Works Consulted
Aberg JA, et al. (2009). Primary care guidelines for the management of persons infected with HIV: 2009 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases, 49(5): 651–681.
American College of Obstetricians and Gynecologists (2008). Prenatal and perinatal human immunodeficiency virus testing: Expanded recommendations. ACOG Committee Opinion No. 418. Obstetrics and Gynecology, 112(3): 739–742.
Antiretroviral Therapy Cohort Collaboration (2003). Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: Analysis of prospective studies. Lancet, 362(9385): 679–686.
Del Rio C, Curran JW (2010). Epidemiology and prevention of acquired immunodeficiency syndrome and human inmmunodeficiency virus infection. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 1, pp. 1635–1661. Philadelphia: Churchill Livingstone Elsevier.
Eron JJ Jr, Hirsch MS (2008). Antiviral therapy of human immunodeficiency virus infection. In KK Holmes et al., eds., Sexually Transmitted Diseases, 4th ed., pp. 1393–1421. New York: McGraw-Hill.
Kitahata MM, et al. (2009). Effect of early versus deferred antiretroviral therapy for HIV on survival. New England Journal of Medicine. Published online April 1, 2009 (doi:10.1056/NEJMoa0807252).
Mocroft A, et al. (2003). Decline in AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377): 22–29.
Rerks-Ngarm S, et al. (2009). Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. New England Journal of Medicine, 361(23): 2209–2220.
Thompson MA, et al. (2010). Antiretroviral treatment of adult HIV infection: 2010 Recommendations of the International AIDS Society—USA Panel. Journal of the American Medical Society, 304(3): 321–333.
U.S. Centers for Disease Control and Prevention (2009). Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR, 58(Early Release): 1–207.
World Health Organization (2009). Antiretroviral therapy for HIV infection in adults and adolescents: Rapid advice. Available online: http://www.who.int/hiv/pub/arv/rapid_advice_art.pdf.
World Health Organization (2009). HIV and infant feeding, revised principles and recommendations: Rapid advice. Available online: http://whqlibdoc.who.int/publications/2009/9789241598873_eng.pdf.
World Health Organization (2009). Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Rapid advice. Available online: http://www.who.int/hiv/pub/mtct/rapid_advice_mtct.pdf.
eMedicineHealth Medical Reference from Healthwise
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.